Analyst Ratings for Checkmate Pharmaceuticals (CMPI) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/6/2021 | BofA Securities » Updated 3/31/2022 |
Geoff Meacham | Upgrade | Buy (Neutral) |
6.00 (7.00) |
3.86 (10.50) |
172.02% | Details |
9/1/2020 | Jefferies » Updated 3/19/2021 |
Maury Raycroft | New Coverage | Buy (N/A) |
19.00 (23.00) |
15.58 (10.50) |
-32.61% | Details |